Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Imazio

Showing results (111-120 of 480) with videos related to

Pageof 48
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 30, 2021
Pericarditis in patients with COVID-19: a systematic reviewCarlos Diaz-Arocutipa, Jose Saucedo-Chinchay, Massimo Imazio
Expert Review of Cardiovascular Therapy|November 12, 2019
Contemporary diagnosis and treatment of recurrent pericarditisAlessandro Andreis, Massimo Imazio, Gaetano Maria de Ferrari
Postgraduate Medicine|February 1, 2017
Contemporary management of pericardial effusion: practical aspects for clinical practiceMassimo Imazio, Luca Gaido, Alberto Battaglia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 22, 2007
CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials--two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationaleMassimo Imazio, Enrico Cecchi, Salvatore Ierna, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 2, 2007
Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd rationaleMassimo Imazio, Enrico Cecchi, Salvatore Ierna, et al.
Arthritis and Rheumatism|August 1, 2009
Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et alAntonio Brucato, Massimo Imazio, David Spodick, et al.
Heart (British Cardiac Society)|January 26, 2020
Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomesMassimo Imazio, Marzia Colopi, Gaetano Maria De Ferrari
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Colchicine for the treatment of cardiovascular diseases: old drug, new targetsAlessandro Andreis, Massimo Imazio, Gaetano Maria De Ferrari
Nature Reviews. Cardiology|August 12, 2015
Recurrent pericarditis: new and emerging therapeutic optionsMassimo Imazio, George Lazaros, Antonio Brucato, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 4, 2020
COVID-19 and myocardial injury: is there a role for interleukin-1 inhibition?Massimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari
Pageof 48

Showing results (111-120 of 480) with videos related to

Sort By:
Pageof 48
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 30, 2021
Pericarditis in patients with COVID-19: a systematic reviewCarlos Diaz-Arocutipa, Jose Saucedo-Chinchay, Massimo Imazio
Expert Review of Cardiovascular Therapy|November 12, 2019
Contemporary diagnosis and treatment of recurrent pericarditisAlessandro Andreis, Massimo Imazio, Gaetano Maria de Ferrari
Postgraduate Medicine|February 1, 2017
Contemporary management of pericardial effusion: practical aspects for clinical practiceMassimo Imazio, Luca Gaido, Alberto Battaglia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 22, 2007
CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials--two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationaleMassimo Imazio, Enrico Cecchi, Salvatore Ierna, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 2, 2007
Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd rationaleMassimo Imazio, Enrico Cecchi, Salvatore Ierna, et al.
Arthritis and Rheumatism|August 1, 2009
Pathogenetic mechanisms, new drugs, and old problems in idiopathic recurrent pericarditis: comment on the article by Picco et alAntonio Brucato, Massimo Imazio, David Spodick, et al.
Heart (British Cardiac Society)|January 26, 2020
Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomesMassimo Imazio, Marzia Colopi, Gaetano Maria De Ferrari
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Colchicine for the treatment of cardiovascular diseases: old drug, new targetsAlessandro Andreis, Massimo Imazio, Gaetano Maria De Ferrari
Nature Reviews. Cardiology|August 12, 2015
Recurrent pericarditis: new and emerging therapeutic optionsMassimo Imazio, George Lazaros, Antonio Brucato, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 4, 2020
COVID-19 and myocardial injury: is there a role for interleukin-1 inhibition?Massimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari
Pageof 48